CBD at 5 mg/kg/day failed to prevent bone loss in ovariectomized rats and actually increased bone resorption markers — ruling it out as a standalone osteoporosis treatment while confirming safety.
Postmenopausal women considering CBD, osteoporosis researchers, and clinicians advising on CBD use
What the researchers found
CBD (5 mg/kg/day for 12 weeks) did not prevent OVX-induced trabecular bone loss, increased bone resorption markers versus OVX controls, and showed no significant effect on cannabinoid receptor expression or bone metabolism genes in sham-operated rats.
Why it matters
CBD is promoted for many conditions including bone health — this well-designed negative result protects consumers from ineffective treatment and redirects research toward more promising approaches.
The numbers in context
CBD 5 mg/kg/day via osmotic pumps for 12 weeks; OVX/CBD trabecular bone decreased similarly to OVX/vehicle; increased bone resorption markers in OVX/CBD vs OVX/vehicle; no Ctsk gene reduction (unlike estradiol).
How the study worked
12-week controlled study with 5 groups of rats (sham/vehicle, sham/CBD, OVX/vehicle, OVX/estradiol, OVX/CBD), using micro-CT, serum bone markers, and gene expression analysis.
What this study cannot tell us
Single dose tested (5 mg/kg/day); osmotic pump delivery may not reflect oral bioavailability; rat OVX model may not fully represent human postmenopausal bone loss; 12-week study may miss very long-term effects.
How to read the evidence
Well-controlled preclinical study with multiple outcome measures and appropriate comparators, providing clear negative evidence.
When this study was published
Published in 2026, providing important negative evidence for the CBD-bone health claim.
The bigger picture
Negative results are essential for evidence-based medicine — CBD being safe for bones but ineffective at preventing loss means women shouldn't rely on it as an osteoporosis strategy.
Questions still open
- Would higher CBD doses show different results? Could CBD combined with other cannabinoids or standard therapies have synergistic bone effects?
Common questions
Can CBD help with osteoporosis?
Is CBD at least safe for bones?
Read the original research
Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats.
JBMR plus, 10(2), ziaf197
Citation
Chanpaisaeng, Krittikan; Fleet, James C; Rawiwet, Visut; Phonsatta, Natthaporn; Panya, Atikorn; Panupinthu, Nattapon; Charoenphandhu, Narattaphol. (2026). Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats.. JBMR plus, 10(2), ziaf197. https://doi.org/10.1093/jbmrpl/ziaf197
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk